Cas:23291-69-2 2,4-Dimethyl-5-nitro-1H-benzimidazole manufacturer & supplier

We serve Chemical Name:2,4-Dimethyl-5-nitro-1H-benzimidazole CAS:23291-69-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,4-Dimethyl-5-nitro-1H-benzimidazole

Chemical Name:2,4-Dimethyl-5-nitro-1H-benzimidazole
CAS.NO:23291-69-2
Synonyms:2,4-dimethyl-5-methylene-4,5-dihydro-furan-3-carboxylic acid tert-butyl ester;2,4-dimethyl-5-methylene-4H-furan-3-carboxylic acid tert-butyl ester;2,4-dimethyl-5-nitrobenzimidazole;TERT-BUTYL 2,4-DIMETHYL-5-METHYLIDENE-4H-FURAN-3-CARBOXYLATE
Molecular Formula:C9H9N3O2
Molecular Weight:191.18700
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:74.50000
Exact Mass:191.06900
LogP:2.61110

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,4-dimethyl-5-methylene-4,5-dihydro-furan-3-carboxylic acid tert-butyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,TERT-BUTYL 2,4-DIMETHYL-5-METHYLIDENE-4H-FURAN-3-CARBOXYLATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-dimethyl-5-nitrobenzimidazole Use and application,TERT-BUTYL 2,4-DIMETHYL-5-METHYLIDENE-4H-FURAN-3-CARBOXYLATE technical grade,usp/ep/jp grade.


Related News: Health officials said it remained unclear where he had developed the disease. 2,4-Dimethyl-5-nitro-1H-benzimidazole manufacturer Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production. 2,4-Dimethyl-5-nitro-1H-benzimidazole supplier The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers. 2,4-Dimethyl-5-nitro-1H-benzimidazole vendor During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. 2,4-Dimethyl-5-nitro-1H-benzimidazole factory The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.